Delivery Order SPE2DR25D2104-SPE2DR26F3PUJ
- Not listed
- The Defense Logistics Agency awarded a $24,180.49 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on October 31, 2025, with completion scheduled for November 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency awarded a $19,727.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-competitive delivery order, issued on September 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The pharmaceutical product will be delivered...
- The Defense Logistics Agency awarded a $117,680.89 delivery order to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was awarded on December 12, 2025, with an ultimate completion date of December 15, 2025,...
- The Defense Logistics Agency awarded a delivery order valued at $11,793.61 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. The contract, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,196.25 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on November 20, 2025. This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of November 21, 2025, with performance to be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $41,246.60 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at approximately $54k. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $3,776.73 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $1,796.37 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, executed on December 8, 2025, with completion targeted for December 9, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $27,357.91 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, firm fixed-price delivery order was issued on September 22, 2025, with a completion date of September 23, 2025, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PUJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors, valued at $2,392.50. This competitively awarded, firm fixed price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The order is scheduled for completion by November 25, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Repatha is a PCSK9 inhibitor used in cardiovascular disease management for cholesterol reduction in patients with familial hypercholesterolemia or established cardiovascular disease. This delivery order reflects the ongoing utilization of AmerisourceBergen's comprehensive prime vendor agreement to supply specialty pharmaceuticals and medical supplies supporting military healthcare programs and other federal medical systems. The award demonstrates the company's continued role as a critical pharmaceutical distributor within the Defense Logistics Agency's medical supply chain, fulfilling specific medication requirements for military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/23/25 |